English|RELX Starts China’s First Clinical Study on E-Cigarette Safety
文章图片
BEIJING, February 7 (TMTPOST) — Chinese e-cigarette maker RELX’s clinical study on the safety of e-cigarettes has been registered successfully on ChiCTR (China Clinical Trial Registry).
【English|RELX Starts China’s First Clinical Study on E-Cigarette Safety】RELX’s research project is said to be the first clinical study to focus on the safety of e-cigarettes in China.
The company also started a clinical study on e-cigarettes earlier in March 2021. The clinical study last year focused on the impact of using e-cigarettes and conventional cigarettes on the biomarkers in human bodies. The study has been completed and the research findings will be released later this year.
Different from the previous study that focused on the metabolism of nicotine, RELX’s new study will focus on key indicators of the clinical study participants’ respiratory function and cardiovascular function to study e-cigarettes’ impact on human bodies.
The study will be conducted by the Sun Yat-sen University-RELX Product Review Lab. The lab is the first lab in China that studies atomization in both clinical and non-clinical projects.
The study will recruit 36 healthy test participants with a smoking habit, according to Professor Zhong Guoping, deputy director of the Sun Yat-sen University-RELX Product Review Lab. Test participants will be put into randomized groups for researchers to observe e-cigarettes’ short-term impact on participants’ respiratory function and cardiovascular function.
Clinical studies are generally conducted for the research and development of new drugs. They are used for assessing the safety and effectiveness of drugs. RELX had conducted a series of research products in physics, chemistry and biology to prove e-cigarettes’ safety.
China has not yet built a comprehensive knowledge and research system on e-cigarettes. The country announced in November 2021 that e-cigarette products fall into the category of tobacco products and are regulated by tobacco law and regulation. China also aims to have stricter control over the production, sales and marketing of e-cigarettes. In December 2021, China’s State Tobacco Monopoly Administration began seeking public opinions on its draft e-cigarette standard guidelines, which specify the nicotine strength limit for e-cigarettes and warns the public about potential health issues that might arise from using e-cigarettes.
推荐阅读
- English|India Further Hits Chinese Firm as Huawei Faces Multiple Tax Raids
- English|Apple CEO Tim Cook Faces Backlash for His US$99 Million Pay Package
- English|User of 58.com Kidnapped to Cambodia After Clicking Fake Job Ad
- English|Volkswagen to Acquire Huawei’s Autonomous Driving Unit
- English|Li Auto CTO Said to Step Down Less Than Two Years in Job amid Reorganization
- English|Maimai Launches Company Review Function
- English|LinkedIn to Focus on Localization and New Strategy in China
- English|Scientists Might Have Cured a Woman of HIV for the First Time with Stem Cell Transplant
- English|The Making of Teenage Olympic Gold Medalist and Commercial Star Eileen Gu
- English|Xiaomi Dismisses Massive Layoff Rumor: We Have More Than 4000 Job Openings